HCW Biologics is trading at $1.75, up 5.42% in after-hours trading, with no clear company-specific catalyst identified for the rebound.
- Shares closed the September 23, 2026 regular session at $1.66.
- The latest notable announcement was a September 4 distribution agreement with Akron Biotech, reported September 22, involving staged payments totaling $500,000.
- Broader market weakness does not explain the opposite-direction after-hours move.